Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Metabolic Syndrome and Risk of Breast Cancer by Molecular Subtype: Analysis of the MEND Study

Clinical Breast Cancer(2021)10.1016/j.clbc.2021.11.004Source: DataRank Database

Metabolic Syndrome and Risk of Breast Cancer by Molecular Subtype: Analysis of the MEND Study is a research paper published in Clinical Breast Cancer (2021). On theSindex it has a DataRank of 0. It has been cited 13 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access13 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 0.73)OA: hybridTopics (42)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (22)

Taofik Oyekunle,Omolola Salako ORCID,Anjali Gupta ORCID,Olusegun Isaac Alatise ORCID,Gabriel Olabiyi Ogun ORCID

Live enrichment

PubMed:34980540 OpenAlex:https://openalex.org/W3217777560

Fogarty International Center

Grant: K01TW010271

National Institutes of Health

Grant: 1P30DK124723-01

North Carolina Diabetes Research Center

National Institutes of Health

Grant: 5K01TW010271-05

Metabolic Syndrome and Epigenetic Markers of Breast Cancer in Nigerian Women

Wellcome Trust

Grant: unidentified

unidentified

NIDDK NIH HHS

Grant: P30 DK124723

Wellcome Trust

FWCI

0.73

Citation Percentile

0.7%

Citation Trend

2022

2023

2024

2025

2026

hybridLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.clbc.2021.11.004

publisherhttps://doi.org/10.1016/j.clbc.2021.11.004

publisherhttps://api.elsevier.com/content/article/PII:S1526820921003207?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1526820921003207?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34980540

Fields of Study

Cancer Risks and FactorsMetabolism, Diabetes, and CancerDiabetes, Cardiovascular Risks, and Lipoproteins03 medical and health sciences0302 clinical medicineBreast NeoplasmsFemaleHumansMetabolic SyndromeOdds RatioRisk FactorsTriple Negative Breast NeoplasmsWaist Circumference

MeSH Terms

Breast NeoplasmsFemaleHumansRisk FactorsOdds RatioMetabolic SyndromeWaist CircumferenceTriple Negative Breast Neoplasms

Keywords

MedicineBreast cancerOncologyInternal medicineCancerMetabolic syndromeGynecologyObesityRisk FactorsOdds RatioHumansBreast NeoplasmsFemaleTriple Negative Breast NeoplasmsWaist CircumferenceArticleCholesterolDiabetesHypertensionNigeriaTriple-negative breast cancer

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being